430 related articles for article (PubMed ID: 19878098)
1. Remifentanil post-conditioning attenuates cardiac ischemia-reperfusion injury via kappa or delta opioid receptor activation.
Wong GT; Li R; Jiang LL; Irwin MG
Acta Anaesthesiol Scand; 2010 Apr; 54(4):510-8. PubMed ID: 19878098
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal morphine preconditioning induces cardioprotection via activation of delta, kappa, and mu opioid receptors in rats.
Li R; Wong GT; Wong TM; Zhang Y; Xia Z; Irwin MG
Anesth Analg; 2009 Jan; 108(1):23-9. PubMed ID: 19095826
[TBL] [Abstract][Full Text] [Related]
3. Remifentanil preconditioning confers cardioprotection via cardiac kappa- and delta-opioid receptors.
Zhang Y; Irwin MG; Wong TM; Chen M; Cao CM
Anesthesiology; 2005 Feb; 102(2):371-8. PubMed ID: 15681953
[TBL] [Abstract][Full Text] [Related]
4. Remifentanil preconditioning protects the small intestine against ischemia/reperfusion injury via intestinal δ- and μ-opioid receptors.
Shen JT; Li YS; Xia ZQ; Wen SH; Yao X; Yang WJ; Li C; Liu KX
Surgery; 2016 Feb; 159(2):548-59. PubMed ID: 26410664
[TBL] [Abstract][Full Text] [Related]
5. Remifentanil preconditioning protects against ischemic injury in the intact rat heart.
Zhang Y; Irwin MG; Wong TM
Anesthesiology; 2004 Oct; 101(4):918-23. PubMed ID: 15448525
[TBL] [Abstract][Full Text] [Related]
6. Morphine postconditioning protects against reperfusion injury in the isolated rat hearts.
Chen Z; Li T; Zhang B
J Surg Res; 2008 Apr; 145(2):287-94. PubMed ID: 18155248
[TBL] [Abstract][Full Text] [Related]
7. ARD-353 [4-((2R,5S)-4-(R)-(4-diethylcarbamoylphenyl)(3-hydroxyphenyl)methyl)-2,5-dimethylpiperazin-1-ylmethyl)benzoic acid], a novel nonpeptide delta receptor agonist, reduces myocardial infarct size without central effects.
Watson MJ; Holt JD; O'Neill SJ; Wei K; Pendergast W; Gross GJ; Gengo PJ; Chang KJ
J Pharmacol Exp Ther; 2006 Jan; 316(1):423-30. PubMed ID: 16188952
[TBL] [Abstract][Full Text] [Related]
8. Acute methadone treatment reduces myocardial infarct size via the delta-opioid receptor in rats during reperfusion.
Gross ER; Hsu AK; Gross GJ
Anesth Analg; 2009 Nov; 109(5):1395-402. PubMed ID: 19843777
[TBL] [Abstract][Full Text] [Related]
9. Ischemic preconditioning and morphine-induced cardioprotection involve the delta (delta)-opioid receptor in the intact rat heart.
Schultz JJ; Hsu AK; Gross GJ
J Mol Cell Cardiol; 1997 Aug; 29(8):2187-95. PubMed ID: 9281450
[TBL] [Abstract][Full Text] [Related]
10. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
Solinas M; Goldberg SR
Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
[TBL] [Abstract][Full Text] [Related]
11. Activation of central opioid receptors induces cardioprotection against ischemia-reperfusion injury.
Wong GT; Ling Ling J; Irwin MG
Anesth Analg; 2010 Jul; 111(1):24-8. PubMed ID: 19861363
[TBL] [Abstract][Full Text] [Related]
12. Remifentanil preconditioning protects rat cardiomyocytes against hypoxia-reoxygenation injury via δ-opioid receptor mediated activation of PI3K/Akt and ERK pathways.
Dou MY; Wu H; Zhu HJ; Jin SY; Zhang Y; He SF
Eur J Pharmacol; 2016 Oct; 789():395-401. PubMed ID: 27492364
[TBL] [Abstract][Full Text] [Related]
13. Ischemic preconditioning in the intact rat heart is mediated by delta1- but not mu- or kappa-opioid receptors.
Schultz JE; Hsu AK; Gross GJ
Circulation; 1998 Apr; 97(13):1282-9. PubMed ID: 9570199
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the antidysrhythmic effects of delta- and kappa-opioid receptor agonists and antagonists on calcium chloride-, adrenaline- and ischemia/reperfusion-induced arrhythmias in rats.
Valtchanova-Matchouganska A; Missankov A; Ojewole JA
Methods Find Exp Clin Pharmacol; 2004; 26(1):31-8. PubMed ID: 14988739
[TBL] [Abstract][Full Text] [Related]
15. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
16. Remifentanil preconditioning confers delayed cardioprotection in the rat.
Yu CK; Li YH; Wong GT; Wong TM; Irwin MG
Br J Anaesth; 2007 Nov; 99(5):632-8. PubMed ID: 17872933
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of remifentanil against transient focal cerebral ischemia in rats.
Jeong S; Kim SJ; Jeong C; Lee S; Jeong H; Lee J; Yoo KY
J Neurosurg Anesthesiol; 2012 Jan; 24(1):51-7. PubMed ID: 22015431
[TBL] [Abstract][Full Text] [Related]
18. Activation of kappa-opioid receptors at reperfusion affords cardioprotection in both rat and mouse hearts.
Peart JN; Gross ER; Reichelt ME; Hsu A; Headrick JP; Gross GJ
Basic Res Cardiol; 2008 Sep; 103(5):454-63. PubMed ID: 18500486
[TBL] [Abstract][Full Text] [Related]
19. Cardiac μ-opioid receptor contributes to opioid-induced cardioprotection in chronic heart failure.
He SF; Jin SY; Yang W; Pan YL; Huang J; Zhang SJ; Zhang L; Zhang Y
Br J Anaesth; 2018 Jul; 121(1):26-37. PubMed ID: 29935580
[TBL] [Abstract][Full Text] [Related]
20. Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival.
Kim HS; Cho JE; Hwang KC; Shim YH; Lee JH; Kwak YL
Eur J Pharmacol; 2010 Feb; 628(1-3):132-9. PubMed ID: 19944681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
